FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311750302> ?p ?o ?g. }

• W4311750302 abstract "Abstract Background Staphylococcus aureus prosthetic valve infective endocarditis (SA-PVIE) is associated with high mortality. Gentamicin (GEN) with anti-staphylococcal antibiotics and rifampin are guideline recommendations for SA-PVIE extrapolated from in vitro data. GEN can lead to acute kidney injury (AKI), meanwhile, the clinical benefit on infection-related outcomes remains unclear. Therefore, we evaluated the impact of GEN on outcomes in SA-PVIE. Methods This is a multicenter, retrospective cohort conducted at HonorHealth and UCHealth systems. Adults admitted between January 2014-2022 with definite/possible SA-PVIE by Duke Criteria were included if they received ≥2 days of treatment within 2 days of index culture. Cohorts were stratified by GEN receipt. The primary outcome was 90-day all-cause mortality. The secondary outcomes were treatment failure (change in antimicrobials, abscess development, new indication for cardiac surgery), 30-day all-cause mortality, and incidence of AKI by KDIGO Criteria. Results Overall, 38 patients with definite (40%) and possible SA-PVIE (60%) met inclusion (13 GEN, 25 without GEN [no-GEN]). At baseline, 15 (40%) patients were in an ICU, median Pitt bacteremia score was 2, and methicillin-susceptible S. aureus predominated (71%). A total of 10 (26%) patients had valve surgery; median bacteremia duration was similar between GEN and no-GEN (4 vs 3 days, p = 0.26). Common antibiotics were vancomycin (95%), cefazolin (63%), and nafcillin (21%); rifampin was more common in GEN than no-GEN (20% vs 77%, p &lt; 0.001). Baseline AKI (44% vs 46%) and renal impairment (8% vs 0%) were not different between GEN and no-GEN, respectively. GEN was initiated a median 3 days after index culture, most commonly as intermittent strategy (69%) with 3 mg/kg daily equivalent (84.6%). There was no statistical difference in treatment failure (23% vs 24%, p=0.17), 30-day mortality (20% vs 39%, p=0.22), or 90-day mortality (28% vs 43%, p=0.263) between GEN and no-GEN, respectively. Three in the (23%) GEN group experienced AKI, compared to 10 (40%) in no-GEN. Conclusion We did not find that the addition of GEN to SA-PVIE therapy enhanced mortality benefit, yet patients without GEN may live to experience adverse events. Further studies were warranted. Disclosures All Authors: No reported disclosures." @default.
• W4311750302 created "2022-12-28" @default.
• W4311750302 creator A5014675014 @default.
• W4311750302 creator A5024830276 @default.
• W4311750302 creator A5032782498 @default.
• W4311750302 creator A5062398935 @default.
• W4311750302 creator A5088333098 @default.
• W4311750302 date "2022-12-01" @default.
• W4311750302 modified "2023-10-16" @default.
• W4311750302 title "1986. Multicenter evaluation of <i>Staphylococcus aureus</i> prosthetic valve infective endocarditis with and without gentamicin treatment: Is it time to revisit?" @default.
• W4311750302 doi "https://doi.org/10.1093/ofid/ofac492.1611" @default.
• W4311750302 hasPublicationYear "2022" @default.
• W4311750302 type Work @default.
• W4311750302 citedByCount "0" @default.
• W4311750302 crossrefType "journal-article" @default.
• W4311750302 hasAuthorship W4311750302A5014675014 @default.
• W4311750302 hasAuthorship W4311750302A5024830276 @default.
• W4311750302 hasAuthorship W4311750302A5032782498 @default.
• W4311750302 hasAuthorship W4311750302A5062398935 @default.
• W4311750302 hasAuthorship W4311750302A5088333098 @default.
• W4311750302 hasBestOaLocation W43117503022 @default.
• W4311750302 hasConcept C126322002 @default.
• W4311750302 hasConcept C141071460 @default.
• W4311750302 hasConcept C2775832221 @default.
• W4311750302 hasConcept C2775872228 @default.
• W4311750302 hasConcept C2777052132 @default.
• W4311750302 hasConcept C2778353156 @default.
• W4311750302 hasConcept C2778651397 @default.
• W4311750302 hasConcept C2778980435 @default.
• W4311750302 hasConcept C2779443120 @default.
• W4311750302 hasConcept C2779489039 @default.
• W4311750302 hasConcept C2780176578 @default.
• W4311750302 hasConcept C501593827 @default.
• W4311750302 hasConcept C523546767 @default.
• W4311750302 hasConcept C54355233 @default.
• W4311750302 hasConcept C71924100 @default.
• W4311750302 hasConcept C86803240 @default.
• W4311750302 hasConcept C89423630 @default.
• W4311750302 hasConceptScore W4311750302C126322002 @default.
• W4311750302 hasConceptScore W4311750302C141071460 @default.
• W4311750302 hasConceptScore W4311750302C2775832221 @default.
• W4311750302 hasConceptScore W4311750302C2775872228 @default.
• W4311750302 hasConceptScore W4311750302C2777052132 @default.
• W4311750302 hasConceptScore W4311750302C2778353156 @default.
• W4311750302 hasConceptScore W4311750302C2778651397 @default.
• W4311750302 hasConceptScore W4311750302C2778980435 @default.
• W4311750302 hasConceptScore W4311750302C2779443120 @default.
• W4311750302 hasConceptScore W4311750302C2779489039 @default.
• W4311750302 hasConceptScore W4311750302C2780176578 @default.
• W4311750302 hasConceptScore W4311750302C501593827 @default.
• W4311750302 hasConceptScore W4311750302C523546767 @default.
• W4311750302 hasConceptScore W4311750302C54355233 @default.
• W4311750302 hasConceptScore W4311750302C71924100 @default.
• W4311750302 hasConceptScore W4311750302C86803240 @default.
• W4311750302 hasConceptScore W4311750302C89423630 @default.
• W4311750302 hasIssue "Supplement_2" @default.
• W4311750302 hasLocation W43117503021 @default.
• W4311750302 hasLocation W43117503022 @default.
• W4311750302 hasOpenAccess W4311750302 @default.
• W4311750302 hasPrimaryLocation W43117503021 @default.
• W4311750302 hasRelatedWork W1971982169 @default.
• W4311750302 hasRelatedWork W1979569779 @default.
• W4311750302 hasRelatedWork W2033135215 @default.
• W4311750302 hasRelatedWork W2046084936 @default.
• W4311750302 hasRelatedWork W2061663421 @default.
• W4311750302 hasRelatedWork W2136046416 @default.
• W4311750302 hasRelatedWork W2150339728 @default.
• W4311750302 hasRelatedWork W2152192688 @default.
• W4311750302 hasRelatedWork W2155139966 @default.
• W4311750302 hasRelatedWork W157981307 @default.
• W4311750302 hasVolume "9" @default.
• W4311750302 isParatext "false" @default.
• W4311750302 isRetracted "false" @default.
• W4311750302 workType "article" @default.